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Traditionally, astrocytic mRNA and protein expression are studied by in situ hybridization
(ISH) and immunohistochemically.This led to the concept that astrocytes lack aralar, a com-
ponent of the malate-aspartate-shuttle. At least similar aralar mRNA and protein expression
in astrocytes and neurons isolated by fluorescence-assisted cell sorting (FACS) reversed
this opinion. Demonstration of expression of other astrocytic genes may also be erro-
neous. Literature data based on morphological methods were therefore compared with
mRNA expression in cells obtained by recently developed methods for determination of
cell-specific gene expression. All Na,K-ATPase-α subunits were demonstrated by immuno-
histochemistry (IHC), but there are problems with the cotransporter NKCC1. Glutamate
and GABA transporter gene expression was well determined immunohistochemically. The
same applies to expression of many genes of glucose metabolism, whereas a single study
based on findings in bacterial artificial chromosome (BAC) transgenic animals showed very
low astrocytic expression of hexokinase. Gene expression of the equilibrative nucleoside
transporters ENT1 and ENT2 was recognized by ISH, but ENT3 was not.The same applies to
the concentrative transporters CNT2 and CNT3. All were clearly expressed in FACS-isolated
cells, followed by biochemical analysis. ENT3 was enriched in astrocytes. Expression of
many nucleoside transporter genes were shown by microarray analysis, whereas other
important genes were not. Results in cultured astrocytes resembled those obtained by
FACS.These findings call for reappraisal of cellular nucleoside transporter expression. FACS
cell yield is small. Further development of cell separation methods to render methods more
easily available and less animal and cost consuming and parallel studies of astrocytic mRNA
and protein expression by ISH/IHC and other methods are necessary, but new methods
also need to be thoroughly checked.
Keywords: astrocyte culture, BAC transgenic animals, fluorescence-assisted cell sorting, GFAP, immunohistochem-
istry, in situ hybridization
INTRODUCTION
Enzymes and transporters, involved in production and degrada-
tion of glutamate and GABA are expressed in astrocytes. Some
have been known for a long time to be astrocyte-specific, e.g.,
glutamine synthetase (GS) (1), pyruvate carboxylase (2), and
cytosolic malic enzyme (3). However, identification of either
mRNA or protein expression in astrocytes in the brain in vivo
or intact brain tissue, such as brain slices, is difficult on account of
its extreme anatomical complexity. Conventional immunohisto-
chemical methods seem occasionally to fail in demonstrating the
Abbreviations: AGC, glutamate/aspartate exchanger; BAC, bacterial artificial chro-
mosome; BGT, low-affinity GABA transporter; CNT, Concentrative nucleoside
transporters; COX, cytochrome oxidase; DMS, direct mRNA sequencing; dBcAMP,
dibutyryl cyclic AMP; EAAT, glutamate transporters; ENT, equilibrative nucleoside
transporters; FACS, fluorescence-assisted cell sorting; Fgfr, fibroblast growth factor
receptor; GATs, high-affinity subtypes GABA transporters; GFAP, glial fibrillary
acidic protein; GS, glutamine synthetase; α-KG, α-ketoglutarate; MAS, malate-
aspartate-shuttle; OAA, oxaloacetate; OGC, malate/α-ketoglutarate exchanger; PI,
propidium iodide; RT-PCR, reverse transcription-polymerase chain reaction; TCA,
tricarboxylic acid.
expression of certain genes, as recently demonstrated in the case
of aralar, a glutamate/aspartate exchanger operating in the malate-
aspartate-shuttle (MAS). Its abundant mRNA (4) and protein (5)
expression has been demonstrated by usual biochemical methods
in freshly isolated mouse astrocytes and in well differentiated cul-
tured astrocytes (5). However, gene expression of the aralar gene
has repeatedly been found to be absent or sparsely expressed when
morphology-based immunochemical methods were used, as will
be described in Section“Determination of the Expression of Genes
Involved in Different Pathways using Different Methodologies.”
Traditional morphology-based methods for studying cell type-
specific gene expression in brain in vivo or in excised brain tissues
are in situ hybridization (ISH) and immunohistochemistry (IHC),
analyzing mRNA and protein expression, respectively. Immuno-
cytochemistry (ICC) is used for the same purpose in isolated cells.
A technique, which has been newly established for adult brain,
fluorescence-assisted cell sorting (FACS) yields highly purified
populations of different types of brain cells (4, 6). It uses insertion
of a fluorescent compound into the cell by aid of the promoter
of an astrocyte-specific gene, such as glial fibrillary acidic protein
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(GFAP) or S100β, a principle developed for insertion of green flu-
orescent protein (7), and thus depends upon preservation of an
intact cell. This and related methods are often used for determina-
tion of mRNA expression by microarray analysis, a quantitatively
less accurate method, as evident from Tables 1 and 2, where dif-
ferent results quite often were obtained by different authors and
from results by Hertz et al. (8), where consistency between dif-
ferent samples in some cases was poor. Nevertheless it is useful
because of its requirement for very little tissue. This is a neces-
sity for simultaneous determination of the expression of multiple
genes, since the cell yield by FACS is small. The microarray analysis
provides numbers, not a direct indication whether a specific gene
is expressed or not. Therefore a numerical analysis is needed. In
the paper by Lovatt et al. (4) the authors interpret several results
as indicating whether a gene is expressed or not, but in their pub-
lished Table (9) only numbers are presented. In reference (9), they
also present a Table showing a comparison with non-astrocytes
in the case of Lovatt et al. (4), and neurons in the case of Cahoy
et al. (6) and indicate fold-enrichment and P values. This table has
been used in connection with the Lovatt (4) and Doyle (10) data
in Tables 1 and 2 in the present paper, whereas the Cahoy data
is based upon the numbers in the comprehensive Table provided
by (6). This is because astrocyte expression, not enrichment is the
topic of this paper.
The microarray analysis by Doyle et al. (10) also provides num-
bers. However, their analysis was not based on FACS but was
based on generation of transgenic mice that expressed the riboso-
mal protein L10a in a cell-specific manner. Since this protein had
been tagged with enhanced green fluorescent protein (EGFP), they
could check proper cell-specific labeling by the green fluorescence
and simultaneously use anti-GFP antibodies for immunopurifi-
cation to enrich ribosome-associated, actively translated mRNAs.
This procedure allowed them to bypass the cell separation pro-
cedure and instead use a total cell homogenate. The astrocytic-
specific Aldh1L1 (6) was used for their studies of astrocytic gene
expression. The methodology employed in each of these studies is
described in more detail in Section “Cell Sorting Based on Recog-
nition of Cell-Specific Proteins.” Here it suffices to note that in
spite of the different procedures employed in these three studies,
and although Lovatt et al. (4) and Doyle et al. (10) used adult mice,
and the oldest mice studied by Cahoy et al. (6) were 17-day-old,
the results are relatively, although far from completely, similar. In
Table 1 the two methods are therefore indicated close to each other,
with all microarray results in red.
Table 1 | Expression of astrocytic genes determined by different methodologies.
Protein title Gene mRNA Protein Gene
In situ
hybridization
FACS
RT-PCR
Microarray Culture
RT-PCR
Immuno-
histochemistry
Culture
Aralar Slc25a12 Present (5) + (4)+ (6)+ (10) Present (5) Absent (11, 12) Present (5) Slc25a12
Present (13)
GLAST Slc1a3 Present (14, 15) + (4)+ (6)+ (10) Present (16, 17) Present (18) Slc1a3
GLT-1 Slc1a2 Present (19, 20) + (4)+ (6)+ (10) Present (21) Present (22, 23) Slc1a2
GAT1 Slc6a1 Present (24, 25) + (4)+ (6)+ (10) Present (26) Slc6a1
GAT 2 Slc6a13 Present (24, 26) − (4)− (6)− (10) Present (26, 27) Slc6a13
GAT 3 Slc6a11 Present (26, 27) + (4)+ (6)+ (10) Present (28, 29) Slc6a11
BGT 1 Slc6a12 − (4)− (6)− (10) Present (30, 31) Slc6a12
ENT1 Slc29a1 Present (32, 33) Present (34) − (4)+ (6)+ (10) Present (35) Slc29a1
ENT2 Slc29a2 Present (32) Present (34) − (4)+ (6)+ (10) Present (35) Slc29a2
ENT3 Slc29a3 Present (34) − (4)+ (6)+ (10) Present (35) Slc29a3
ENT4 Slc29a4 Present (34) − (4)− (6)+ (10) Absent (36) Slc29a4
CNT1 Slc28a1 Absent (34) Present (37) Slc28a1
CNT2 Slc28a2 Absent (33) Present (34) − (4)− (6)+ (10) Present (35) Slc28a2
CNT3 Slc28a3 Low expression (33) Present (34) − (4) Absent (35) Slc28a3
Na,K-ATPase α1 Atp1a1 Present (38–40) − (4)+ (6)− (10) Present (41) Present (41) Atp1a1
Na,K-ATPase α2 Atp1a2 Present (40, 42) Present (43) + (4)+ (6)+ (10) Present (41) Present (41) Atp1a2
NKCC1 Slc12a2 Present (42, 44, 45) − (4)+ (6)+ (10) Present (46) Slc12a2
The data for aralar, Na,K-ATPase, and the nucleoside transporters are supposed to be comprehensive, whereas those for transporters involved in glutamate/GABA
turnover are rather representative, at least with respect to immunohistochemistry and in situ hybridization. Genes consistently found to be expressed by all methodolo-
gies are shown in blue, those only found absent in one study in green, and results from studies using FACS-isolated astrocytes in red. As described in the text, microarray
data were assigned as either positive or negative based on the number values in the microarray analysis itself [(6) http://www.stanford.edu/group/exonarray/cgi-
bin/plot_selector.pl] and fold-enrichment and significance [6] and [10] as shown by Lovatt and Nedergaard (9), but using less stringent criteria with respect to fold
enrichment (≥1.5) than in the original publications. This was found to be justifiable, because the microarray data here are used together with other data, but in the
original publications as the only indication of gene presence. Reference numbers given in this Table refer to those in the reference list.
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Table 2 | Drug effects on gene expression and editing in astrocytes are identical in freshly isolated cells from treated animals and primary
cultures of astrocytes, but the expression is often not recognized by the microarray analyses, indicatest as + or −.
Protein Gene Drug FACS Culture Microarray
(4) (6) (10) [4*]
5-HT2B receptor expression Htr2b Fluox Up Up − − −
5-HT2B editing Htr2b Fluox Up Up
5-HT2c receptor expression Htr2c Fluox Unchanged Unchanged − − −
cPLA2a Pla2g4a Fluox Up Up − − − +
sPLA2 Pla2g2a Fluox Unaltered Unaltered − − −
ADAR2 Adarb1 Fluox Up Up − − − −
GluK2 expression Grik2 Fluox Up Up + + − −
GluK2 editing Grik2 Fluox Up Up
GluK4 expression Grik4 Fluox Unchanged Unchanged − − − −
cfos expression cFos Fluox Up Up − + − +
fosB expression Fosb Fluox Up Up − + − +
NBCe1 Slc4a4 Cbz Up Up + + + +
GluK2 Grik2 Cbz Down Down
cPLA2 Pla2g4a Cbz Up Up
TheTable shows all experiments in which we have compared drug [fluoxetine (Fluox) or carbamazepine (Cbz)] effects in cultured astrocytes and in astrocytes obtained
by FACS. Complete agreement was found between these two preparations, but the correlation was poor with expression of the same genes obtained using microarray
analysis and with the cultures, different from ours, studied by Cahoy et al. using microanalysis (4*). The FACS and culture data are from (47) and (48). Microarray data
show only gene expression and are from Lovatt et al. [4], Cahoy et al. [6] and Doyle et al. [10] Cahoy et al. (6) also presented data for cultures different from ours,
shown under [4]. As in Table 1, expression is shown as either present (+) or absent (−) based on the number values in the microarray analysis itself [2 and 4] or
fold-enrichment and significance [1] and [3] shown by Lovatt and Nedergaard (9).
If only expression of a single or a few genes are analyzed,
FACS-isolated cells can also be used for a more accurate determina-
tion of mRNA by reverse transcription-polymerase chain reaction
(RT-PCR), requiring larger cell samples, and even of protein by
Western blot followed by reaction with a specific antibody, needing
still more tissue. Gene expression in primary cultures of astrocytes
has also been utilized as a method to determine astrocytic char-
acteristics. Some recent papers criticizing this technique (49, 50)
have unjustifiably failed to recognize that many types of astrocytic
cultures exist and that they are not all identical. The cultures used
by ourselves differ vastly both in methodology and characteristics
from those previously used by Harold Kimelberg and from those
discussed by Foo et al. (50). In contrast to those used by Foo et al.
(50) they are grown in the presence of serum and they are dif-
ferentiated by treatment with dibutyryl cyclic AMP (dBcAMP),
necessary for the development of certain specific features, e.g.,
K+-induced glycogenolysis (51) a well established phenomenon
in intact brain tissue (52). In contrast to many other astrocyte
cultures prepared from rats they are obtained from mice (53).
Peculiarly enough, this does make a difference (54), e.g., in mem-
brane conductance, which these authors found comparable only
in mouse cells with the high membrane conductance characteristic
of astrocytes in the brain in vivo.
The discrepancy regarding expression of the aralar gene
between freshly isolated astrocytes and those studied in intact
tissue by IHC raises the question whether expression of other
important genes may be underestimated in the literature. This
will be discussed in the present review by a comparison between
results of determination of astrocytic gene expression in intact
tissues, freshly isolated cells and cultures, presented in Section
“Determination of the Expression of Genes Involved in Differ-
ent Pathways using Different Methodologies.” Some additional
enzymes involved in glucose metabolism will be discussed in
Section “Expression of Genes of Enzymes Catalyzing Glucose
Metabolism,” a few of those involved in the glutamate-glutamine
cycle in Section “Enzymes and Transporters Operating in Glu-
tamate and GABA Turnover,” several of those involved in astro-
cytic ATP signaling (nucleoside transporter and adenosine kinase
expression) in Section “Nucleoside Transporters and Adenosine
Kinase,” and those involved in K+ homeostasis in Section “Expres-
sion of Genes of Transporters Involved in K+ Clearance from the
Extracellular Space.” The two former are directly relevant for the
present Research Topic. The two latter represent other important
astrocytic functions, and are discussed, although more briefly, to
better evaluate potential failures of some methodologies to dis-
close astrocytic gene expression. These sections will be followed by
more detailed descriptions of individual methodologies in Section
“Description of Methodologies Used for Determination of Gene
Expression.”
DETERMINATION OF THE EXPRESSION OF GENES INVOLVED
IN DIFFERENT PATHWAYS USING DIFFERENT
METHODOLOGIES
EXPRESSION OF GENES OF ENZYMES CATALYZING GLUCOSE
METABOLISM
Lack of astrocytic aralar expression in immunohistochemical
studies versus prominent mRNA and protein expression in freshly
isolated cells
Oxidative metabolism is needed by astrocytes for two major pur-
poses, (i) to supply ATP for energy-consuming processes, and
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(ii) sto produce glutamate from glucose. This glutamate produc-
tion is crucial for the production of transmitter glutamate and
GABA, since glutamate does not easily enter the brain from the
systemic circulation (55). The occurrence of one oxidative process
during glycolysis, which generates NADH from NAD+ and the
inability of NAD+ and NADH themselves to cross the mitochon-
drial membrane require that“reducing equivalents”are transferred
across the mitochondrial membrane. Some shuttle mechanisms
exist that are capable of doing this, but only the MAS is expressed
in brain at a significant level as discussed by Dienel and Hertz
(56). In the cytosol, reduction of oxaloacetate (OAA) to malate
enables cytosolic NADH oxidation to NAD+, and malate can be
transferred across the mitochondrial membrane for re-oxidation
(Figure 1). In MAS it enters the mitochondria in exchange with α-
ketoglutarate (α-KG), using the malate/α-ketoglutarate exchanger
(OGC – Slc25a11). OGC expression is similar in synaptic and non-
synaptic mitochondria (12), it is functional in astrocytes ((13) – see
also Pardo et al. in this research Topic), and OGC is expressed in
freshly isolated astrocytes (6). After its re-oxidation in the tricar-
boxylic acid (TCA) cycle to OAA, the latter becomes transaminated
to the corresponding amino-acid, aspartate. Aspartate can exit
across the mitochondrial membrane in exchange with glutamate,
using the glutamate/aspartate exchanger (AGC). After its arrival
in the cytosol glutamate is converted to OAA, closing the cir-
cle. Both mitochondrial and cytosolic aspartate aminotransferases
(57–59) in brain are well established, and aspartate aminotrans-
ferase activity is high in cultured astrocytes (60, 61). Nevertheless,
histochemistry failed to show expression of the enzyme by histo-
chemistry in some studies (62, 63), although moderate astrocytic
expression had previously been shown (64). This is peculiar in
light of unhindered demonstration by the same authors of the
expression of glutamate dehydrogenase (GDH), a mitochondrial
enzyme which also metabolizes glutamate (63). Both the cytosolic
(Got1) and the mitochondrial (Got2) aspartate aminotransferase
gene have been demonstrated in freshly isolated astrocytes (4, 6).
There are two different AGC forms, in adult brain almost exclu-
sively AG1 or aralar (Slc25a12), with only small clusters of citrin
(Slc25a13) in a few neurons (65). MAS cycle activity is needed
for formation of glutamate and GABA in brain, which is well
known to occur readily and to depend upon pyruvate carboxylase-
mediated (2, 66) glutamine formation in astrocytes. It therefore
came as a big surprise when the operation of MAS in astrocytes
in situ was questioned due to an observed absence of aralar (and
citrin) in astrocytes in situ (11). This would make appropriate
oxidative metabolism of glucose impossible. Ramos et al. reported
that only little aralar expression is found in cultured astrocytes
and even less in astrocytes of the adult brain. Berkich et al. (12)
confirmed absence of astrocytic aralar using a different antibody.
Finally, Pardo et al. (13), using an improved immunofluorescent
assay with antigen retrieval and identifying astrocytes histolog-
ically, reported presence of aralar protein in astrocytes in the
mouse brain, but only in relatively small amounts. However, in
freshly isolated astrocytes and neurons obtained by fluorescence-
activated cell separation (FACS) both microarray analysis (4) and
RT-PCR (5) showed at least as much mRNA expression in adult
astrocytes as in adult neurons, and the levels of expression were
FIGURE 1 | In the malate–aspartate shuttle (MAS) cytosolic malate
dehydrogenase (MDHc) oxidizes NADH and converts oxaloacetate
(OAA) to malate (top right of figure), which enters the mitochondria in
exchange with α-ketoglutarate (α-KG). The mitochondrial malate
dehydrogenase (MDHm) re-oxidizes malate to OAA, which is transaminated
to aspartate by the mitochondrial aspartate aminotransferase (AATm).
Aspartate leaves the mitochondria in exchange with glutamate, requiring
ACG (aralar or citrin). In the mitochondria glutamate conversion to α-KG is
essential for AATm activity forming aspartate from OAA and delivering α-KG
for mitochondrial export. The glutamate imported into the mitochondria had
been formed by cytosolic aspartate aminotransferase (AATc) from α-KG
after its entry into the cytosol. Without MAS activity NADH formed in the
cytosol during glycolysis would have been unable to enter the mitochondria
for oxidation. Reprinted from Hertz and Dienel (69), with permission.
comparable to those in whole brain. Since expression of mRNA
is not necessarily accompanied by protein expression, Li et al. (5)
also determined protein expression of aralar, which was found
to match its mRNA expression in cells from 35-day-old animals,
whereas the expression was much lower in cells (both neurons and
astrocytes) from 14-day-old animals (Figure 2). A similar slow
development of aralar expression was shown in astrocyte cultures
(Figure 2), and both the level of expression and the developmental
course were similar in the freshly isolated cells and in the cultures
used. Thus, there is no reason to doubt MAS function in astrocytes,
although several immunohistochemical studies had indicated that
this could not be the case.
The discrepancy between results obtained by IHC and FACS
followed by RT-PCR and Western blot could be caused by: (i) use
of GFAP to identify astrocytes in the studies by Ramos et al. (11)
and Berkich et al. (12), since GFAP is absent from the fine processes
that contain a large number of mitochondria (4); (ii) loss of anti-
genicity upon tissue fixation or tissue processing. That both points
may be important is shown by the fact that Pardo et al. (13), the
only authors who have demonstrated aralar immunohistochemi-
cally (i) relied on cell morphology, not GFAP presence to classify
a cell as astrocytic, and (ii) also were the only ones to use antigen
retrieval, a procedure that partly can overcome artifacts from fixa-
tion or tissue processing. Nevertheless, the consistency in the lack
of ability to demonstrate aralar histochemically between several
different groups underlines that this is not due to methodological
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FIGURE 2 | Protein and mRNA expression of aralar in astrocytes and
neurons isolated by FACS from cerebral hemispheres of 14- and
35-day-old astrocyte-labeled [F VB/NTg(GFAP-GFP)14Mes/J] or
neuron-labeled [B6.Cg-Tg(Thy1-YFPH)2Jrs/J] mice and in intact brain
of adult CD-1 mice. (A) A representative immunoblot showing protein
expression for aralar and β-actin, used as a house-keeping protein. The size
of aralar is 70 kDa, and of β-actin 46 kDa. Similar results were obtained
from three independent experiments. (B) Means±SEM of scanned ratios
between aralar and β-actin. *Statistically significant (P <0.05) difference
from the same preparation from 14-day-old animals. (C) A representative
amplification plot of aralar mRNA expression, determined by real-time
PCR. Similar results were obtained from three independent experiments.
For analysis of graph, see Xu et al., under revision. (D) Means±SEM
(n=3) of the relative expression ratio of aralar. *Statistically significant
(P <0.05) difference from the same preparation from 14-day-old animals.
From (5).
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errors in a single study, but to systematic, unexplained deficiencies
within the methodologies. For some reason demonstration of the
expression of many astrocytic genes is enigmatic.
Expression of genes of other enzymes involved in glucose
metabolism
The discrepancy between results for aralar expression obtained by
immunohistochemical analysis and by mRNA and protein deter-
mination raises the question whether a similar apparent failure of
histochemistry to identify and accurately quantify expression of
an important astrocytic gene also may apply to other genes. Lovatt
et al. (4) carried out a microarray analysis of mRNA expression of a
multitude of TCA cycle enzymes in FACS-isolated cells and found
most of them to be expressed at higher levels in astrocytes than in
neurons. In addition, these enzymes in freshly isolated astrocytes
were functionally active, although to an undefined degree. How-
ever, Doyle et al. (10) reported much higher level of hexokinase
gene expression in neurons than in astrocytes from bacterial arti-
ficial chromosome (BAC) transgenic mice, one of the newly estab-
lished techniques (for more information see Fluorescence-Based
Cell Sorting). This contrasts not only immunochemical studies
(67), but also general concepts about energy metabolism in brain.
Thus, Nehlig et al. (68) observed similar total glucose phosphory-
lation in astrocytes and neurons in intact brain tissue. Moreover,
in the primary cultures used in our laboratory, the rate of glucose
oxidative metabolism in astrocytes and cerebellar granule cells is
quite similar, 1.2 and 1.0 nmol/mg protein per min [Table 6 in
Ref. (69)], which is comparable with in vivo rates [reviewed by
Ref. (70)]. One may therefore wonder if the animals used to study
neuronal gene expression have shown more perfect labeling of
their genome than those used for determination of astrocytically
expressed genes. This should not conceal that many preparations
of cultured astrocytes also show a very low rate of oxygen con-
sumption (71), again emphasizing that not all astrocyte cultures
are identical, and that many show characteristics making them
unsuited as models for astrocytes in vivo. At least some enzymes
involved in oxidative metabolism of glucose (and other substrates)
have also been demonstrated immunohistochemically, since dis-
tinct astrocytic demonstration of cytochrome oxidase (COX) has
been shown in sections from the monkey striate cortex (72). Astro-
cytes, but not neurons and probably also not oligodendrocytes
show immunohistochemically determined expression of pyruvate
carboxylase (2, 73), which is consistent with the operation of this
enzyme in cultured astrocytes (66). The repeated demonstration
of this enzyme in astrocytes is of crucial importance, since it is
necessary for net synthesis of TCA cycle intermediates and thus
for astrocytic production from α-KG of glutamate in astrocytes,
needed for neuronal production of transmitter glutamate and
GABA. Cultured astrocytes also express cytosolic, but not mito-
chondrial malic enzyme as shown both immunocytochemically
(3) and by anion exchange chromatography to separate the cytoso-
lic and mitochondrial isoforms of malic enzyme (74), whereas
adult rat brain express the two isoforms about equally (suggest-
ing neuronal localization of the mitochondrial form). There is
consensus that cytosolic malic enzyme operates during complete
oxidative metabolism of glutamate, converting it to pyruvate after
its exit from the TCA cycle.
ENZYMES AND TRANSPORTERS OPERATING IN GLUTAMATE AND
GABA TURNOVER
Norenberg and Martinez-Hernandez (1) performed immunohis-
tochemical analysis of GS in rat nervous system and showed that
the enzyme was astrocyte-specific. The stain was confined to the
cytoplasm and perivascular astrocytic processes. The intensity of
staining varied between different brain locations, with highest level
in hippocampus and cerebral cortex. GS expression has repeatedly
been confirmed in astrocytic cultures [e.g., Ref. (75, 76)]. Pres-
ence of GS has also been claimed in oligodendrocytes in brain
and spinal cord (77–79). However, oligodendrocytic manifesta-
tion was not described during the original demonstration of GS
expression in astrocytes (1), and the absence of GS expression in
oligodendrocytes has been confirmed by Derouiche (80) and again
by Anlauf and Derouiche in the present Research Topic. The reader
is referred to this paper for further discussion of this topic, which
is important for understanding of both oligodendrocytic function
and difficulties in correct demonstration of gene expression.
How glutamine transport is directed from astrocytes to neu-
rons was long unknown, since no obvious differences were found
between kinetics for glutamine uptake in astrocytes, cultured glu-
tamatergic or GABAergic neurons, and neuronal perikarya pre-
pared by gradient centrifugation (81). This problem has received
its solution with the demonstration of different glutamine trans-
porters in neurons and astrocytes. The bi-directional transporter
SN1, also known as SNAT3 is abundantly expressed in astrocytic
processes surrounding glutamatergic and GABAergic neurons and
its expression is pronounced in the neocortex, cerebellum, olfac-
tory bulb, and brain stem (82). The possibility that its absence
from neuronal terminals could be due to insufficient antigen
detection has been excluded by the demonstration that possible
SN1/synaptophysin coexpression is rare (83). This system N trans-
porter transfers glutamine in symport with Na+ and in antiport
with H+, which is important for its role specifically in glutamine
efflux from astrocytes (84). Its regulation by protein kinase C
(PKC) is discussed in this Research Topic by Nissen-Meyer and
Chaudhry. A potential role of its relative SN2 in some brain regions
and its subcellular distribution have been discussed by Hamdani
el et al. (85).
Released glutamate from glutamatergic neurons is mainly
taken up by astrocytes ((86) – see also Zhou and Danbolt in
this Research Topic), where it is either oxidative metabolized
(∼20%) or converted to glutamine and re-transferred to neu-
rons in the glutamine-glutamate cycle. Aspartate aminotransferase
and/or GDH are involved in the conversion of glutamate to α-
ketoglutarate. Aspartate aminotransferases were discussed above
and astrocytic localization of GDH has been shown immunohisto-
chemically by Aoki et al. (87) and Würdig and Kugler (63) and its
gene expression has been demonstrated in FACS-sorted astrocytes
by Lovatt et al. (4) and Cahoy et al. (6) using microarray analysis. It
is reason for concern that astrocytic expression of this gene was not
observed by Doyle et al. (10) in their study using BAC animals. In
contrast, the genes shown to be expressed in Table 1 were as well
recognized in the study by Doyle et al. (10) as in the two other
microarray studies. Thus this methodology seems for unknown
reasons to have difficulty demonstrating only the expression of
certain astrocytic genes.
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The astrocytically located cytosolic malic enzyme discussed
above is responsible for α-ketoglutarate’s complete oxidation in
the TCA cycle after conversion to malate and exit of malate to
the cytosol. A larger fraction of released GABA than of released
glutamate is re-accumulated in the neurons themselves but some
is metabolized in the astrocytic TCA cycle after conversion to
succinate via GABA transaminase (GABA-T) and succinic alde-
hyde dehydrogenase (SSADH) (see paper in this Research Topic
by Schousboe et al.). GABA-T has been demonstrated histochem-
ically in both neurons and astrocytes (88), consistent with GABA
uptake in both cell types.
Among the five subtypes of glutamate transporters (exci-
tatory amino-acid transporters; EAATs 1–5), astrocytes express
l-glutamate/l-aspartate transporter (GLAST; EAATl) and GLT-
l (EAAT2). Lehre et al. (15) and Chaudhry et al. (16) stained
brain slices for GLAST protein and concluded it was expressed
in astrocytes. Later, Schmitt et al. (14) compared GLAST mRNA
and protein expression in the CNS of rat. They found that GLAST
mRNA was located in the cytoplasm of astrocytes. In Bergmann
cells, GLAST mRNA stain also appeared in proximal processes.
Protein stain showed similar pattern, but fine processes that were
not labeled with GFAP were also stained for GLAST. In the retina
GLAST expression even in the finest Müller cell processes had
previously been shown by Derouiche and Rauen (17). GLAST
expression varies in astrocytes in different brain regions. In cere-
bellum, Bergmann cells showed strong reaction, but the granule
cell layer showed only faint astrocytic labeling (14). GLT-1 is
expressed in astrocytes of the mature brain and spinal cord (19,
20). Although GLAST expression is distributed within all cor-
tical layers, and strongly expressed throughout the granule cell
layer of the dentate gyrus of the hippocampus, experiments with
a GLT-1-preferring inhibitor, WAY-855 showed that GLT-1 was
responsible for 80% glutamate uptake in isolated hippocampal
tissue (89). Selective inhibition of GLT-1 with WAY-855 does
not completely prevent glutamate build-up, but NMDA receptor-
mediated neurotoxic effects remain, suggesting additional roles of
other glutamate transporters in extracellular glutamate mainte-
nance. However, an authoritative review by Danbolt (86) has also
concluded that GLT-1 is the dominant glutamate transporter in
cortical astrocytes and that GLT-1 and GLAST together account
for the predominant astrocytic uptake of glutamate in the brain
in vivo.
Kinetics for glutamate uptake has been determined by different
authors in primary cultures of astrocytes, where the uptake can
be extremely intense (90). Swanson et al. (91) and Schlag et al.
(22) found that primary cultures of rat astrocytes express GLAST,
but little or no GLT-1, and that treatment with dBcAMP, known
to increase intracellular cAMP, enhanced the expression of both
GLAST and GLT-l. This observation was made by both ICC and
mRNA and protein determination. Nevertheless, GLT-1 expres-
sion was only a fraction of that observed in brain tissue (22).
Co-culturing with neurons had a similar effect as the cAMP ana-
log. dBcAMP treatment also increased Vmax for glutamate uptake
(22), although it only reached about one half of its value in mouse
cultures found by Hertz et al. (90). GLT-1 expression in cultured
astrocytes can also be enhanced by activation of additional signal-
ing pathways (23), and it would be extremely useful to establish
an astrocyte culture with as high GLT-1 expression as in the brain
in vivo.
Some released transmitter GABA is taken up by astrocytes,
although the uptake rate in cultured astrocytes is much slower
than that of glutamate (92) and also slower than in cultured neu-
rons (93). GABA uptake is mediated by one of three high-affinity
subtypes of GABA transporters (GATs), GATl, GAT2, and GAT3
or in some cases by the one low-affinity transporter BGTl. Astro-
cytes can express all four subtypes [for review, see Ref. (25)].
GAT1 is present in astrocytes in all brain regions, where IHC
demonstrated punctate structures that were shown by electron
microscopy to be located exclusively in the small cell processes
(26). In cerebellum, GAT1 mRNA was detected in Bergmann cells
[for review, see Ref. (25)]. In rat thalamus GAT1 and GAT3 pro-
teins are mainly expressed in astrocytes and the stain of GAT3
is more intense than that of GAT1 (28). In the parabrachial and
Kölliker-Fuse nuclei GAT3 was detected, whereas GAT1 was absent
(29). Cerebellar mRNA and protein staining of GAT2 and GAT3
was also primarily glial, with GAT2 stain in the granule layer and
GAT3 stain in the deep nuclei (24, 27). Nevertheless, FACS iso-
lation followed by microarray analysis showed the GAT2 gene as
not expressed in brain (6, 9) a similar result was reached in cere-
bellum using BAC transgenic mice (10). With respect to most
other glutamate and GABA transporters there is virtual consensus
by all methods that they are expressed in astrocytes. An excep-
tion is BGT-1 mRNA, which is observable in cerebellum of BAC
transgenic mice (Table 1), although not with sufficiently high fold
change for unequivocal demonstration (10). It has also has been
reported in cultured astrocytes (30), although up-regulation of
this betaine-GABA transporter did not affect GABA uptake (31).
NUCLEOSIDE TRANSPORTERS AND ADENOSINE KINASE
There are two types of nucleoside transporters, the concentra-
tive CNTs l–3, which are able to transport nucleosides against
an intracellular/extracellular gradient of the nucleoside itself, and
the equilibrative ENTs l–4. CNTs are necessary for termination
of adenosine and guanosine transmitter effects by cellular uptake,
regardless of cellular requirements. ENTs, like other equilibrative
transporters, carry out transport only until equilibrium has been
established between intra- and extracellular concentrations (94).
Most nucleoside transporters are membrane-bound, but ENT3
is mainly intracellular (33), and may distribute adenosine into
intracellular organelles (34).
mRNA expression of ENT1 and ENT2 mRNA, determined by
ISH, is widespread in the brain (32), and the presence of both
of these transporters has been reported in both astrocytes and
neurons in a review by Parkinson et al. (33). The same review
claimed that CNT2 and CNT3 were absent in astrocytes, and no
information was provided about ENTs 3 and 4. Moreover, the
impression was given that astrocyte expression of the remain-
ing transporters was low. However, this information seems to be
misleading, since mRNA for all nucleoside transporters except
CNT1 are expressed to at least a similar degree (in relation to
applied amount of RNA and to a house-keeping gene) in astro-
cytes as in neurons in freshly isolated astrocytes (34) (Table 1).
Analysis using either FACS-sorted cells or BAC transgenic animals
also demonstrates most of them although with some differences
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between different investigators and especially good recognition by
Doyle et al. (10). The astrocytic enrichment in ENT3 was dramatic
(Figure 3), opening the possibility that gliotransmitter ATP may be
synthesized in intracellular organelles, which has been confirmed
by downregulation of ENT3 by siRNA (Xu et al., under revision).
It is consistent with intense astrocytic but not neuronal formation
of AMP, ADP, and ATP in cultured cells (95) that adenosine kinase,
the enzyme converting adenosine to AMP in the adult brain, has
been found by IHC to be selectively expressed in astrocytes (96).
However, Parkinson et al. (97) reported very little nucleotide for-
mation in astrocyte cultures, perhaps reflecting immaturity of the
cells used, and again emphasizing that different astrocyte cultures
may behave differently. As illustrated for ENT3 in Figure 3, the
expression of ENTs and CNTs shown in freshly isolated cells has
been replicated in our cultured cells (35, 43) with the exception of
CNT3, which is sparsely expressed in brain.
EXPRESSION OF GENES OF TRANSPORTERS INVOLVED IN K+
CLEARANCE FROM THE EXTRACELLULAR SPACE
Two astrocytic membrane proteins mediate uptake of extracellu-
lar K+ ([K+]e), Na,K-ATPase and NKCCl, which is an inwardly
directed Na+, K+, 2Cl− cotransporter expressed both in cul-
tured astrocytes (98–100) and mature astrocytes in vivo (101,
102). The Na,K-ATPase operates alone below a total [K+]e of
∼10 mM. At higher [K+]e, NKCC1 plays a dominant role, as
shown by inhibition with bumetanide or furosemide, inhibitors
of the cotransporter (103–105).
Na, K-ATPase contain α and β subunits. Three isoforms of its
α subunits (α1–3) and 2 of its β subunits β1 and β2) are expressed
in brain (38, 39). Immunofluorescent histochemistry showed that
ATPase α1 protein is expressed both in neurons and glia, and its
glial expression is obvious in co-cultures (41). Only Cahoy et al.
(6) indicate expression of α1 mRNA after microarray analysis in
spite of its demonstration by histochemistry, ISH (in cultures) and
also after FACS separation followed by RT-PCR (43). The failure
FIGURE 3 | mRNA expression measured by RT-PCR of α1, α2, and α3
isoform of Na,K-ATPase in astrocytes isolated by FACS from cerebral
hemispheres in vivo from adult mice [FVB/NTg(GFAP-GFP)14Mes/J].
A representative experiment showing mRNAs for α1, α2, and α3 isoform
and for TBP, as a house-keeping gene. The sizes of the PCR products of α1
is 920 bp, α2 350 bp, α3 329 bp, and TBP 236 bp, n=3. From (43).
of both Lovatt et al. (4) and Doyle et al. (10) to show astrocytic
expression of this gene in, respectively FACS-isolated astrocytes
and astrocytes obtained from BAC mice treated with the astrocytic
marker Aldh1L1 is unfortunate.
Na, K-ATPase α2 expression is primarily in glia, and Na,K-
ATPase α3 is only expressed in neurons (40, 44). Expression of α2
in astrocytes was first suggested by Watts et al. (42), who demon-
strated its mRNA expression with ISH. Its labeling pattern was
diffuse in hippocampus, neocortex, and brain stem. Later, Swead-
ner’s group performed IHC on cerebellar brain slices and ICC on
co-cultures of cerebellar granule cells and astrocytes (41) and con-
solidated their findings by ISH. Staining forα2 in the granular layer
was observed in diffuse processes around granule cells (41) in a
similar staining pattern as that found by McGrail et al. (40). In the
co-cultures α2 staining was extensive in GFAP-positive astrocytes
and it uniformly labeled the surface of the cells (41). Recent exper-
iments using cells obtained by FACS have confirmed α2 expression
in astrocytes (Figure 3) (43) in agreement with the previous obser-
vation by IHC, ICC, ISH, and cell culturing. Microassay analysis
(Table 1) has also consistently shown expression of the gene of the
α2 isoform of the Na,K-ATPase in astrocytes (4, 6, 10).
In situ hybridization showed NKCC1 mRNA located in gran-
ule layer and white matter tract of cerebellum (45). Attempts to
demonstrate NKCC1 immunohistochemically in astrocytes has,
however, also often provided negative results (M. Nedergaard,
personal communication). Nevertheless functional responses to
high extracellular K+ concentrations (swelling or enhanced K+
uptake and their inhibition by a NKCC1 inhibitor) have repeat-
edly identified the astrocytic location of this transporter both in
the superfused monkey brain (106) and cultured astrocytes (104).
Gene expression and phosphorylation of NKCC1 have been stud-
ied in cultured astrocytes under control condition and after trauma
by increased barometric pressure by Jayakumar et al. (107). Silenc-
ing of NKCCl with siRNA led to a reduction in trauma-induced
NKCC1 activity as well as in cell swelling. Microarray results by
both Cahoy et al. (6) and Doyle et al. (10), but not those by Lovatt
et al. (4), also indicate its expression in astrocytes (Table 1).
COMPARISON OF RESULTS OBTAINED BY DIFFERENT METHODOLOGIES
Expression of some, but far from all genes in astrocytes seem to
be impossible to demonstrate or quantitate with IHC and ISH
(Table 1), even using optimized techniques, whereas their expres-
sion is clearly shown in intact cells freshly obtained from the brain.
Biochemical analysis of these cells (determination of mRNA or
protein) gives somewhat more consistent results than microar-
ray analysis. There is no systematic explanation for the failure of
IHC and ISH to show expression of certain genes, and the genes
in question can be located either on the cell membrane (most of
the nucleoside transporters) or intracellularly (aralar and ENT3).
Results obtained by biochemical analysis in cultured astrocytes
(see below) can be very similar to those obtained in vivo, but unfor-
tunately great differences are found between results obtained in
different cultures. The recently introduced BAC transgenic mice
selecting genes co-expressed with the astrocyte-specific Aldh1L1
gene seem also to have severe difficulties in recognizing several
astrocytically expressed genes. There are no overlapping method-
ological mechanisms between this technique and IHC, but there
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might some with ISH, perhaps helping to answer the question
why demonstration of specifically astrocytically expressed genes
is so enigmatic. It would also be interesting to compare astrocytic
gene expression determined in BAC mice selected with a different
astrocyte-specific gene.
DESCRIPTION OF METHODOLOGIES USED FOR
DETERMINATION OF GENE EXPRESSION
IMMUNOHISTOCHEMISTRY AND IMMUNOCYTOCHEMISTRY
By determining the expression of protein, IHC and ICC should be
the ideal tools for demonstrating gene expression in different cell
types. IHC is a laboratory technique that uses specific antibodies
to detect antigens in cells of a tissue section. ICC uses samples
of intact cells without their surrounding extracellular matrix and
contacts to other cells of different types, and is used for many
types of cultured cells. The immunohistochemical study that did
demonstrate aralar (13) used a polyclonal antibody, Ramos et al.
(11) a previously prepared antibody by the same group, and Ber-
kich et al. (12) a donated antibody, recognizing both citrin and
aralar. In general, the binding site of the antibody is unknown
except when a synthesized peptide is used as the antigen. Fixation
is necessary and also difficult. Formaldehyde is the gold standard
for fixation. Its basic mechanism is to form a product between the
formalin and uncharged reactive amino groups (-NH or -NH2)
by aid of cross-links and eventually change the three-dimensional
structure of the proteins [for review, see Ref. (108)]. Overfixa-
tion produces false negative results. Antigen retrieval is usually
used to reverse this conformation change, and among the papers
studying aralar expression immunohistochemically it was used
by Pardo et al. (13), but not in the other publications. In brain
slices, GFAP is generally used as astrocytic marker, for example
by Berkich et al. (12), but not by Pardo et al. (13), who relied
on morphological characteristics. One problem is that GFAP is a
cytoskeleton protein that is rarely distinguishable in all astrocytes
(generally more after cell damage) and that its staining may not
be representative of cytosolic and membrane proteins. Even when
expressed in an astrocyte, GFAP is not present in the peripheral
processes (4, 109) but only expressed in the main stem branching
branches, and often even absent in the cell body. Using GFAP as
a marker in IHC one may therefore significantly underestimate
the abundance of genes of interest expressed in astrocytes (109).
Many other genes and the proteins they code for are astrocyte-
specific in adult animals, including GS, excitatory amino-acid
transporter 2 (EAAT 2), and its rodent analog GLT-1, aquaporin
4, connexin 43 (ctx43), ALDH1L1 (6, 110) as well as the epithe-
lial Na+/H+ exchanger regulatory factors NHERF1, and GLAST
(EAAT-1) (111), with the latter showing pronounced species vari-
ability in the expression of its splice variants (112). An excellent
marker for astrocytes seems to be EGFP introduced into transgenic
mice under the control of the human GFAP promoter (7). This
reporter molecule is a much better astrocytic marker than GFAP,
since GFP is expressed even in the fine processes. GS is another
astrocyte marker which is much better than GFAP (Anlauf and
Derouiche, this Research Project). Thus, it may be possible to
improve immunohistochemical demonstration of astrocytically
expressed genes by discontinuing the use of GFAP as an astro-
cytic marker and rely more on other markers and/or morphology.
The presence of antigen labeling present predominantly in the fine
peripheral astrocyte processes, e.g., ezrin (113) and reelin may
appear as a hazy “background.” This can easily be overlooked,
regardless which astrocyte-specific gene is used for cell identifi-
cation and should be carefully checked for, although this can be
difficult in intact brain.
IN SITU HYBRIDIZATION
The ISH technique is performed in fixed tissue with all cellular
relationships remaining intact. It determines anatomic localiza-
tion of labeled or non-labeled RNA or DNA probes that hybridize
to target complementary RNA or DNA sequences in the cell (114).
These hybrids can be detected using either an isotopic probe and
emulsion autoradiography or non-isotopic methods using spe-
cific antibodies to detect a hapten incorporated into the probe.
Radioisotopic ISH is perceived as providing high sensitivity, quan-
titative labeling, and relatively unambiguous discrimination of sig-
nal versus background, whereas non-radioactive colorimetric ISH
often provides better anatomic localization and discrimination
between cells and is well suited to produce large amounts of data
(114). ISH is limited by providing no information about transla-
tion and posttranslational processes on its own. This obviously also
applies for expression of mRNA determined by different method-
ologies, for example FACS and BAC analysis. Taking advantage of
automated high-throughput procedures and data acquisition ISH
has been used to generate a digital atlas (the freely available Allen
Brain Atlas) showing the expression patterns of approximately
20,000 genes in the adult mouse (115). Potential failure to identify
expression of some astrocytic genes in an unpredictable manner
in this excellent standard reference work would be most regret-
table. Information in general about correlation between protein
and mRNA expression would be valuable and an overall estimate
of the frequency of differences would therefore be very valuable.
Several groups have conducted mRNA/protein correlation
analyses, but the results are controversial. Guo et al. (116) car-
ried out a correlation study for 71 genes using human circulating
monocytes and showed an overall positive correlation. Gry et al.
(117) investigated 23 human cell lines and 1066 genes and found
that only one third of the genes showed significant correlation
between mRNA and protein expression. Schwanhäusser et al. (118)
found better correlation between mRNA and protein levels than
previously thought.
CELL SEPARATION TECHNIQUES, BAC TRANSGENIC MICE,
AND METHODOLOGY FOR mRNA AND PROTEIN
DETERMINATION
MICRODISSECTION AND GRADIENT CENTRIFUGATION
Using the large Deiters’ cell neurons and surrounding neuropil
as well as microanalytic techniques Holger Hydén demonstrated
more than 50 years ago that learning changes the base composition
of nuclear RNA, in both neurons and glia. He also established that
glial cells show more marked and earlier changes in RNA compo-
sition in Parkinson’s disease than neurons. He had the vision and
courage to suggest that “mental diseases could as well be thought
to depend upon a disturbance of processes in glia cells as in the
nerve cells,” and showed that antidepressant drugs cause profound
changes in glial RNA [for review, see Ref. (119, 120)].
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There is no doubt that the neuropil samples constituted less
pure glial samples than present-day astrocytic preparations, but
nevertheless many of Hydén’s observations are presently being
confirmed. A different technique to separate neurons and glia,
gradient centrifugation (121) was used in his laboratory by Ham-
berger and coworkers to show glial uptake of glutamate and GABA
for the first time and many features of their subsequent metabolic
fate (122, 123). Such studies are suitable for determination of Km
values, but the cells are too damaged to evaluate Vmax.
RT-PCR FOLLOWING ELECTROPHYSIOLOGICAL SELECTION OF
ASTROCYTES WITH SPECIFIC RECEPTOR EXPRESSION
The Steinhäuser group has carried out a series of studies com-
bining patch clamp analysis with RT-PCR in studies of AMPA
receptor subunit expression in astrocytes obtained from hip-
pocampal slices (124–126). Facilitated by previous treatment with
enzymes, glial cells expressing AMPA receptors were extracted
after identification based on electrophysiological and immuno-
cytochemical properties, including absence of action potentials.
At the end of the recording, a negative pressure was applied to
the pipette sucking in the cell, the tip of the pipette was bro-
ken off and the cell’s contents were harvested under a micro-
scope as originally described for Purkinje cells by Lambolez
et al. (127). mRNA expression in the collected cells was analyzed
with RT-PCR using repeated amplification and with emphasis on
determination of AMPA receptor subtypes and astrocyte-specific
compounds. The observed changes in splice variant expression
and subunit assembly of AMPA receptors during cell matura-
tion (125) is to be expected due to late generation of astro-
cytes (128) and profound alterations in gene expression and
function in the mouse/rat brain during the first three postnatal
weeks (129, 130).
CELL SORTING BASED RECOGNITION OF CELL-SPECIFIC PROTEINS
Fluorescence-based cell sorting
The possibility to associate a specifically fluorescent drug to either
neurons or astrocytes via their genetic promoters (7) and sub-
sequently sort cells freshly dissociated from the brain accord-
ing to their fluorescent characteristics can greatly improve the
purity of the obtained cell fractions. While Fluorescence-activated
cell sorting (FACS) has long been used in the immunology and
cancer fields, its use in neuroscience was until recently limited
to embryonic brain tissue, cultured cells, stem cells, or synap-
tosomes, because these cells or organelles lack or have fewer
processes than adult neurons and astrocytes (131). Pioneering
studies in Maiken Nedergaard’s and Ben Barres’s laboratories
established this technique for use in adult (4) and adolescent (6)
brain.
A genetically transformed (GFAP-S65T-GFP) mouse was orig-
inally generated by Zhuo et al. (132) from the Messsing group by
inserting a 2.1 kb DNA fragment of the human GFAP promoter
randomly into the mouse genome during oocyte injection of lin-
earized transgene DNA for transgene generation. In many current
references this mouse is called a GFAP-GFP or even GFAP-EGFP
mouse, but it is a GFAP-S65T-GFP mouse. S65T-GFP is a modi-
fied and brighter fluorescent protein than the wild type GFP, but
it is not as bright as EGFP (enhanced GFP) (7). The Nedergaard
laboratory (4) used this mouse in combination with immunohis-
tochemical labeling with anti GLT-1 antibodies to label astrocytes
in adult mice for sorting by FACS. The combination of the two
labels increases the purity of the isolated astrocytes.
Dissociated cells from the cerebral hemispheres of such mice
were sorted and collected by a cell sorting system according to
the wavelength of their fluorescent signal. Cell purity has been
determined by mRNA expression of cell markers of astrocytes
(Gjb6, Gfap, Slc1a2, and Fgfr3), and lack of mRNA from markers
of neurons (Gabra-l, Slc12a5, Snap25, and Syt1), and oligoden-
drocytes (Gjc2, Mag, Mog, and Mbp). A relatively small number
of cells (∼8%) die (become PI+-positive) as a result of the pro-
cedure. Metabolic activity has been demonstrated in similar cells
(4), but not quantitated. The astrocyte sample yield from FACS is
about 1–2µg RNA or 20µg protein per brain which is sufficient
for a multitude of microarray assays (4, 6) or for ∼10 RT-PCR
determinations (5, 34, 43, 47, 133). Our aralar study (5) and fur-
ther FACS studies were carried out using this technique, although
without the GLT-1 antibodies, again with no contamination of the
astrocyte samples with either neurons or oligodendrocytes (133).
Our studies showed that determination of the expression of a
moderate amount of genes (34,43,47) or of a single gene (5) by RT-
PCR yields highly reproducible and comparable results, regardless
whether “classical” RT-PCR or qRT-PCR (real-time RT-PCR) was
used, as can be seen by comparison between Figures 2C and 2D.
The Barres laboratory (6) used FACS combined with immunopan-
ning to isolate astrocytes from transgenic mice that express EGFP
under the control of an S100β promoter.
Cell sorting based on naturally expressed cell-specific genes
A FACS-like method that does not depend on the use of transgenic
animals has been developed for isolation of neurons and endothe-
lial cells by Guez-Barber et al. (131). Specific fluorescent labeling
of neuronal cells was obtained by treating the cells obtained after
brain dissociation with a biotinylated NeuN antibody and subse-
quently with phycoerythrin-labeled streptavidin. Streptavidin has
an extremely high affinity for biotin and phycoerythrin is a protein
that produces a bright red-orange fluorescence, allowing conven-
tional FACS methodology to be used for these cells, selected by
Neu1 expression, and made fluorescent by the subsequent bind-
ing of phycoerythrin-labeled streptavidin. Jungblut et al. (134)
used a related approach to obtain astrocytes from young postnatal
brain. Their cell suspension was first labeled with the anti-GLAST
antibody ACSA-1, conjugated to biotin, whereupon superpara-
magnetic MicroBeads coupled to an anti-biotin antibody were
applied. The cells were resuspended in PBS with 0.5% BSA and
the cell suspension was loaded onto an MS column (Miltenyi
Biotec), which was placed in the magnetic field of a MiniMAC-
STM Separator from the same company. The magnetically labeled
GLAST+ cells were retained within the column and eluted after
removing the column from the magnet. Viability of the cells was
demonstrated by subsequent culturing, showing proliferation and
the formation of a dense layer of GLAST/GFAP double-positive
cells. However, the usefulness of the present modification is lim-
ited by the fact that astrocytes could only be successfully isolated
from P1–P10 mice. When older animals were used, the presence of
cell debris after tissue dissociation interfered with the separation
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performance, lowered the purity of the isolated cells, and dimin-
ished their viability by at least 20%. Use of cells from very young
animals can be gravely misleading because of important postnatal
changes (129, 130).
Cell sorting using bacterial artificial chromosome transgenic mice
Heiman et al. (135) from the Heintz laboratory generated trans-
genic mice that expressed the ribosomal protein L10a tagged with
EGFP. Using these mice one can achieve proper cell-specific label-
ing by green fluorescence and simultaneously use anti-GFP anti-
bodies for immunopurification of ribosomes. Since the ribosomes
carry mRNA for translation, mRNAs that are currently translated
are co-purified. Accordingly, brains from mice of any age can
be obtained and homogenized, and passage of the homogenate
through a column with anti-GFP antibodies or immunoprecipi-
tation will provide the currently translated mRNA in the cell type
studied. In contrast to the FACS/immunopanning approaches cell
viability is of no concern.
For their study of astrocytic gene expression Doyle et al. (10),
also from the Heintz group, did not use the human GFAP pro-
moter (as had been done in the Messing laboratory) but instead
used a different astrocyte-specific (6, 110) marker, Aldh1L1. For
proper transgenic labeling they used long stretches of genomic
DNA (up to 100 MB in size), which can only be manipulated and
amplified as BACs. In these DNA fragments the original gene
is present, with probably all elements required for proper gene
expression. When the open reading frame is replaced by EGFP,
fluorescent cells are obtained [as in the study by Lovatt et al.
(4)], and when it is replaced with L10a-EGFP ribosomes with
adhering mRNA are obtained. Like the much shorter GFAP-EGFP
construct the long BAC construct is injected into mouse oocyte
for transgene generation. BAC transgenic mice have become pop-
ular, since there is a huge repository with BACs for almost all
genes. In addition, there is a huge collection of transgenic mice
generated by this approach (see www.gensat.org). The general
assumption in the field is that BAC transgenes are more specif-
ically expressed than the shorter promoter-using transgene con-
structs. For many cases, this is true, but there are also exceptions.
Aldh1L1 is a rather universal astrocytic marker, and it is almost
unthinkable that Aldh1L1-expressing cells should not express the
α1 unit of the Na,K-ATPase or GDH. It is therefore surpris-
ing (and disappointing) that genes for these proteins were not
recognized in the study by Doyle et al. (10). Future studies of
astrocytic gene expression using BAC mice will determine the gen-
eral validity of this method for determination of astrocytic gene
expression.
Direct mRNA sequencing
A newly developed technique, direct mRNA sequencing (DMS)
(136), allows use of much smaller amounts and is well suited for
determination of gene expression in astrocytic subcompartments
(137). Like the methodologies used by Lovatt et al. (4) and Cahoy
et al. (6) it requires initial isolation of the cells and the subcompart-
ments to be investigated. It has generally been used together with
microarray analysis but could also be used for RT-PCR (137) and
thus enable accurate mRNA determination using smaller amounts
of cells.
Evaluation of the microarray data
The studies by Lovatt et al. (4), Cahoy et al. (6), and Doyle et al.
(10) all investigated astrocytic gene expression, although based on
different astrocyte-specific genes. All used similar microarray pro-
cedures, but different sensitivities and purities are intrinsic to all of
these methods. Most of the results probably overlap for up to 80%
(see also Table 1), but particularly mRNAs with low abundance
might be not detected in one or the other technique. However,
the evasive nature of determination of astrocytic gene expression
seems also occasionally apply to these newer methods. Among the
relatively few genes shown in Table 1, expression of the aralar gene
(Slc25a12) was not recognized in the study by Doyle et al. (10),
which is worrisome. The lack of demonstration of expression of
genes for ENT2 in the Doyle study and for ENT3 in the Lovatt
study (in spite of its strong expression, determined by RT-PCR in
both FACS-isolated cells and cultured cells shown in the present
communication) is also reason for concern. Part of the problem
might be the innate uncertainty of the microarray analysis, a prob-
lem that is obviously not solved by enrollment of additional gene
identification methods. This concept is supported by results from
Table 2, showing identical gene expression and editing determined
in FACS-isolated and cultured astrocytes. However, expression
of many of the same genes were not recognized by Lovatt et al.
(4), using similar isolation procedure but determination of gene
expression by microarray analysis. This applied also to the related
studies by Cahoy et al. (6) and Doyle et al. (10), which also used
microarray analysis. The safest procedure seems accordingly to be
study of the expression of only one or a few genes of immediate
interest and use of enough material (if needed, several animals)
for an analysis by RT-PCR, repeated microarray analysis, or even
better determination of protein by reaction with antibodies. Gen-
erally FACS-separated cells are not used for protein determination
by Western blot and subsequent reaction with a specific antibody
[only exception: aralar determined by (5)], since determination
of multiple antigens (gene under study and house-keeping gene)
by Western blot requires sample sizes between 25 and 75µg pro-
tein (with some variability between the antigens of interest) for
each determination. A single protein determination may therefore
require brains from more than one animal.
PRIMARY CULTURES OF ASTROCYTES
The pioneering technique of Booher and Sensenbrenner (138),
allowing easy preparation of cerebral astrocytes, led to experi-
ments providing many of the first hints of astrocytic characteristics
and gene expression. A wealth of information was obtained, some
of which stands, whereas others were shown to be incorrect, at
least partly dependent upon the culturing method used. The value
of cell culture studies in many different areas of astrocytic biol-
ogy and pathology has been authoritatively reviewed by Lange
et al. (139). The final version of our own cell cultures dates from
1978 (90). These cells are prepared from newborn male or female
mice, and the methodology and functional characteristics have
been described in some detail by Juurlink and Hertz (53), Hertz
et al. (140), and Hertz (141).
The cultures can also be prepared from rats, but the rat astro-
cyte cultures are more contaminated with other cell types (41), and
other differences, including much lower unidirectional K+ influx
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(reduced membrane conductance) have also been reported (41,
54) and remain unexplained. From the age of 14 days, 0.25 mM
dBcAMP is included in the medium. This compound increases
intracellular cyclic AMP and promotes differentiation in astro-
cyte cultures derived from newborn brain (142–144). The age of
2 weeks for its addition has been determined experimentally. This
is consistent with the finding by Moonen and Sensenbrenner (145)
that astrocytes need a certain stage of development in order to
respond to dBcAMP, and that by Lodin et al. (146) that astrocytes
de-differentiate in vitro, unless treated with this compound. Close
similarities between the presently used cultures and freshly isolated
astrocytes in not only levels of aralar protein and mRNA expression
(5) but also rates of developmental changes support their validity
as models of their in vivo counterparts. The same applies to gene
induction following treatment with antidepressant or antibipolar
disorder and their effects on not only gene up-regulation but also
gene editing (47, 48), shown in Table 2. Neuronal cells are absent
in these cultures. They contain <1% of non-parenchymal brain
cells (e.g., meningeal or endothelial cells), a very small number of
microglia (3%) and 95% of the cells are positive for GFAP and for
GS (147). In contrast to the cells cultured by Foo et al. (50) from
the astrocytic cell fraction obtained by their FACS technique from
1-week-old animals, our cultures survive well without growth fac-
tor addition to the media, but serum is routinely present, although
at reduced amounts during later culturing stages. Foo et al. (50)
successfully cultured the cells they obtained and showed that gene
expression in the cultured cells mimicked that in FACS-isolated
cells to a greater extent than the cultured cells (quite different
from our cultured cells) they had previously studied (6).
There are many reasons that all cultured astrocytes are not iden-
tical. Differences in procedures used for preparation of astrocyte
cultures by different authors include species (rats or mice), disso-
ciation methods, amount of cells seeded, and medium used, but
most procedures use new-borne mice or rats. That our cultures
are so highly enriched in astrocytes that they require no subse-
quent cell separation, may be related to the small number of cells
seeded and the small pore size used for filtering the cells. How-
ever, the most important difference between our astrocyte cultures
and those used by other investigators is probably the addition of
dBcAMP from the age of 2 weeks. One reason that we have chosen
to supplement the culturing medium with dBcAMP is that most
noradrenergic innervation from locus coeruleus (to a large extent
contacting astrocytes) is reaching the forebrain at the time of birth
(148). Since this is at the time the cells are harvested for culturing,
they have not received the noradrenergic input which is impor-
tant for brain development in vivo [e.g., Ref. (149)]. One may
wonder if one of the reasons the astrocyte cultures established
by Foo et al. (50) from 1-week-old astrocytes mimic astrocytes
in vivo better than the cultured cells with which they were pre-
pared is that they had received noradrenergic signaling at the
onset of culturing. dBcAMP greatly enhances many characteristics,
including gene expression of aralar (Figure 2). Expression of sev-
eral proteins are altered (142, 143). In many cases it is obviously
difficult to show that these changes make the cells more astro-
cytic, and many astrocytic features develop also without dBcAMP
treatment. However, one important characteristic is that in the
absence of dBcAMP treatment elevated concentrations of K+ fail
to stimulate glycogenolysis, a trait typical for astrocytes in normal
brain tissue (52), whereas they do so after treatment with dBcAMP
(51). dBcAMP was also found to increase the expression of GLT-1,
but not to its level in brain. A goal of future research might be to
establish similar GLT-1 gene expression in the cultures as in astro-
cytes in the brain in vivo. Increased use can be encouraged of good
cultured cells, which by comparison with appropriately analyzed
cell fractions have repeatedly shown to provide reliable results.
SUMMARY
The expression of some astrocytic genes both in freshly isolated
cells and in cultured astrocytes is undoubtedly real as shown by its
repeated demonstration in different preparations using different
techniques. Isolated preparations of astrocytes provide very use-
ful information, but the intricate anatomic connections in adult
brain represent a formidable barrier for preparation of freshly dis-
sociated astrocytes from the adult brain in sufficient amounts. In
spite of continuous progress in analytical methods, which may
also decrease the amount of cellular material needed, the “bot-
tleneck” for use of freshly isolated cells from adult animals by
two different methods (4, 6) remains the lack of inexpensive
and very gentle dissociation methods, preferably yielding large
amounts of cells. Some, but not all, preparations of cultured astro-
cytes have shown themselves to closely resemble freshly isolated
astrocytes in the expression of a multitude of genes. They have
provided crucial information and appear also to be usable for fur-
ther studies. The developmental signals to the cultures delivered
by noradrenergic stimulation may be important determinants of
their “astrocyticity.” Nevertheless, they also have room for further
improvement.
CONCLUSION
Expression of many, but not all astrocytic genes can be appropri-
ately recognized, at least qualitatively, by IHC and ISH. However,
there are very important exceptions. The deficient aralar expres-
sion is probably no longer of major concern, since it has been
contradicted by studies in both freshly dissociated astrocytes and
in cultured cells. Moreover, lack of aralar expression is inconsis-
tent with known astrocytic functions. The deficient qualitative and
in some case quantitative expression of nucleoside transporters
presently seems to represent a much bigger problem, requiring
additional studies and changes of current concepts. Alternative
methods may also fail. It is thus unfortunate that cell separation
followed by microarray analysis in several cases provide different
results in different studies and show negative results even when
FACS sorting followed by determination of gene expression by RT-
PCR and even IHC or ISH have indicated expression of a specific
gene. Development of cheaper and gentler cell separation tech-
niques is also urgently needed, but is bypassed when the method
by Doyle et al. (10) is used. Gene expression determined in cultured
cells can be reliable, but the cells used should have proven them-
selves capable of showing characteristics consistent with those of
astrocytes obtained by other methodologies [Table 2; (50)]. The
fact that several of the astrocytic genes expressed both in freshly
isolated and cultured cells are neither recognized by IHC or ISH,
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nor by the elegant newer cell-labeling techniques even in the hands
of careful investigators is disturbing. It may be even worse that this
seems to happen in a completely unpredictable manner. We have
reviewed some of these genes but are in no doubt that expression
of additional astrocytic genes may remain unrecognized.
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